Table 2 Demographics of patients who (i) were prescribed neural network treatment of choice (NNToC) and (ii) were not prescribed NNToC and significance and external validation on Oxford Health NHS Foundation Trust (OHFT) at treatment initiation. SD standard deviation, MMSE Mini-Mental State Examination, χ2 chi-square test, t Welch’s t-test; P P-value
| Â | Patients prescribed NNToC (n = 222, 12.53%) | Patients prescribed non-NNToC (n = 1550, 87.47%) | Significance |
|---|---|---|---|
Gender (%male) | 28.38% | 39.10% | χ2(1) = 9.15, P = 0.003 |
Age, mean [SD] | 81.12 [7.01] | 82.05 [6.73] | t(282.50) =  − 1.86 P = 0.06 |
MMSE score, mean [SD] | 20.84 [4.89] | 21.06 [5.20] | t(297.27) =  − 0.62 P = 0.53 |
Ethnicity (%Caucasian) | 81.08% | 81.74% | χ2(1) = 0.02, P = 0.88 |
Marital status (%married) | 34.23% | 41.81% | χ2(1) = 4.30, P = 0.04 |